- Home
- TDC vs AMRX Comparison
TDC vs AMRX Comparison
Compare TDC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDC
- AMRX
- Stock Information
- Founded
- TDC 1979
- AMRX 2002
- Country
- TDC United States
- AMRX United States
- Employees
- TDC N/A
- AMRX N/A
- Industry
- TDC Computer Software: Prepackaged Software
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- TDC Technology
- AMRX Health Care
- Exchange
- TDC Nasdaq
- AMRX Nasdaq
- Market Cap
- TDC 2.3B
- AMRX 2.4B
- IPO Year
- TDC 2007
- AMRX N/A
- Fundamental
- Price
- TDC $22.61
- AMRX $7.58
- Analyst Decision
- TDC Hold
- AMRX Strong Buy
- Analyst Count
- TDC 9
- AMRX 5
- Target Price
- TDC $30.00
- AMRX $10.80
- AVG Volume (30 Days)
- TDC 1.0M
- AMRX 2.1M
- Earning Date
- TDC 05-06-2025
- AMRX 05-02-2025
- Dividend Yield
- TDC N/A
- AMRX N/A
- EPS Growth
- TDC 241.18
- AMRX N/A
- EPS
- TDC 1.41
- AMRX N/A
- Revenue
- TDC $1,703,000,000.00
- AMRX $2,830,186,000.00
- Revenue This Year
- TDC N/A
- AMRX $10.49
- Revenue Next Year
- TDC $0.55
- AMRX $7.00
- P/E Ratio
- TDC $16.14
- AMRX N/A
- Revenue Growth
- TDC N/A
- AMRX 13.42
- 52 Week Low
- TDC $18.43
- AMRX $5.18
- 52 Week High
- TDC $38.45
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- TDC 60.86
- AMRX 49.10
- Support Level
- TDC $21.30
- AMRX $7.15
- Resistance Level
- TDC $22.46
- AMRX $7.59
- Average True Range (ATR)
- TDC 0.61
- AMRX 0.31
- MACD
- TDC 0.29
- AMRX 0.03
- Stochastic Oscillator
- TDC 96.87
- AMRX 46.89
About TDC Teradata Corporation
Teradata Corp focused on helping organizations improve business performance, enrich customer experiences, and integrate data across the enterprise. The company's platform provides companies with Harmonized Data: Trusted AI: Teradata VantageCloud: Teradata VantageCore: ClearScape Analytics: and Query Grid. The company generates majority of revenue from the United States.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.